Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
265 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
000404-C
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Participants currently recruited/enrolled
18-75 Years
NCI
Disease X-Linked
18-HG-0064
A Natural History Study of Patients with Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)
Completed Study; data analyses ongoing
0-125 Years
NHGRI
Disease Recessive
00-HG-0209
Molecular and Clinical Studies of Primary Immunodeficiency Diseases
No longer recruiting/follow-up only
3-125 Years
NHGRI
Disease X-Linked
001146-I
A Repository to Study Host-Microbiome Interactions in Health and Disease
Participants currently recruited/enrolled
0-125 Years
NIAID
Disease
001084-CH
A Prospective Natural History Study of Lymphatic Anomalies
Participants currently recruited/enrolled
0-125 Years
NICHD
Disease
001048-I
A Phase 1/2 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-Seronegative Persons
Recruitment has not started
18-22 Years
NIAID
Disease
000894-AR
Natural History of Inflammatory Muscle Diseases
Recruitment has not started
12-125 Years
NIAMS
Disease
000829-H
Controls and Healthy Vasculature Initiative
Participants currently recruited/enrolled
18-125 Years
NHLBI
Disease
000821-I
An Open-Label, Single-Arm, Phase 1/2 Dose-Escalation Trial of Long-Acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
Recruitment has not started
18-75 Years
NIAID
Disease
000809-I
A Pilot Study of Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
Participants currently recruited/enrolled
10-60 Years
NIAID
Disease
000740-CH
A Phase 3 Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia
Enrolling by Invitation
18-125 Years
NICHD
Disease
000697-H
U01 Cooperative Assessment of Late Effects for SCD Curative Therapies (COALESCE)
Participants currently recruited/enrolled
18-65 Years
NHLBI
Disease
000688-I
Longitudinal Observations of Vaccine Responses to SARS-CoV-2 and other Emerging Infectious Diseases
Participants currently recruited/enrolled
18-125 Years
NIAID
Disease
000686-CH
Intrathecal 2-Hydroxypropyl-Beta-Cyclodextrin for Neurological Decline in Patients with Niemann-Pick Disease Type C1
Participants currently recruited/enrolled
18-125 Years
NICHD
Recessive
000674-M
Assessment of [18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects
Participants currently recruited/enrolled
18-99 Years
NIMH
Disease
000665-DK
A Randomized Double-Blind Placebo-Controlled Study of the LEPR Agonist Antibody REGN4461 for the Treatment of Metabolic Abnormalities in Patients with Familial Partial Lipodystrophy
Participants currently recruited/enrolled
18-125 Years
NIDDK
Disease
000633-C
Phase 1/2 Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
000547-HG
Observational Study of Advanced Data Analytics in Genetic Conditions
Recruitment has not started
0-125 Years
NHGRI
Disease
000520-C
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG with or without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
Recruitment has not started
18-125 Years
NCI
Disease
000487-CH
Natural History Investigation into Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism
Participants currently recruited/enrolled
0-125 Years
NICHD
Disease
000464-H
Evaluation of Clonal Hematopoiesis in Patients with Sickle Cell Disease Receiving Curative Therapies
Enrolling by Invitation
4-125 Years
NHLBI
Disease
000392-I
Metabolic Profiling of Immune Responses in Immune-Mediated Diseases
Participants currently recruited/enrolled
18-75 Years
NIAID
Disease
000387-H
The Natural History of Acquired and Inherited Bone Marrow Failure Syndromes.
Participants currently recruited/enrolled
2-125 Years
NHLBI
Disease
000356-C
A Phase I/II Trial of BMS-986253 in Myelodysplastic Syndromes
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
000344-DK
Natural History Study of Parathyroid Disorders
Participants currently recruited/enrolled
0-125 Years
NIDDK
Disease
000343-H
Detection of T cell Somatic Mutations in Bone Marrow Failure Using Whole Exome or Targeted Sequencing
Enrolling by Invitation
18-125 Years
NHLBI
Disease
000331-I
Investigating the Human Immune Response to Ixodes scapularis Tick Bites
Participants currently recruited/enrolled
18-99 Years
NIAID
Disease
000291-I
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Recruitment has not started
18-65 Years
NIAID
Disease
000272-H
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
Participants currently recruited/enrolled
5-45 Years
NHLBI
Disease
000247-DK
Evaluation of Patients with Gastrointestinal Disease
Participants currently recruited/enrolled
18-125 Years
NIDDK
Disease
000226-I
Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy
Participants currently recruited/enrolled
18-75 Years
NIAID
Disease
000207-AR
The Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases; An Observational Prospective Study
Participants currently recruited/enrolled
15-125 Years
NIAMS
Disease
000187-EI
Adaptive Optics Imaging of Outer Retinal Diseases
Participants currently recruited/enrolled
21-125 Years
NEI
Disease
000186-I
Part B- Phase I/II, Non-randomized, Multicenter, Open-label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients with X-Linked Chronic Granulomatous Disease
Clinical hold/Recruitment or enrollment suspended
3-12 Years
NIAID
X-Linked
000152-E
Natural History of The Human Biological Response to Environmental Exposure and Injury
Participants currently recruited/enrolled
18-125 Years
NIEHS
Disease
000124-C
A Phase 2 Study of the MEK inhibitor Trametinib (IND #119346, NSC# 763093) in Children with Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Recruitment has not started
2-21 Years
NCI
Disease
000037-CC
Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis from Existing Radiologic Images
No longer recruiting/follow-up only
0-125 Years
CC
Disease
22-DK-0002
Effect of Ultra-processed versus Unprocessed Diets on Energy Metabolism
Participants currently recruited/enrolled
18-60 Years
NIDDK
Disease
21-I-0029
Natural history, epidemiology and pathogenesis of severe HPV-related diseases (Neptune)
Participants currently recruited/enrolled
3-125 Years
NIAID
Disease
21-HG-0020
Caregiving Networks Across Disease Context and the Life Course: A Comparative Longitudinal Study
Participants currently recruited/enrolled
18-125 Years
NHGRI
Disease
21-CH-0028
A Pilot Study to Evaluate a Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases.
Participants currently recruited/enrolled
18-125 Years
NICHD
Disease
20-M-0082
Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Participants currently recruited/enrolled
18-99 Years
NIMH
Disease
20-I-0132
A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 24-week Phase 3 Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES)
Participants currently recruited/enrolled
12-130 Years
NIAID
Disease
20-HG-0156
A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Assess The Efficacy, Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Venglustat in Late-Onset GM2 Gangliosidosis (Tay-Sachs Disease And Sandhoff Disease)
No longer recruiting/follow-up only
2-125 Years
NHGRI
Disease
20-H-0158
Natural History Study: Gene First Approach to Connective Tissue Disease
Participants currently recruited/enrolled
2-100 Years
NHLBI
Disease
20-H-0099
Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
Enrolling by Invitation
2-120 Years
NHLBI
Disease
20-H-0044
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Disease
20-H-0029
An Intravenous, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
Participants currently recruited/enrolled
18-125 Years
NHLBI
Disease
20-DK-0168
LYNC-LD Prospective Multicenter Natural History Study of Lipodystrophy Syndromes to Determine Prevalence, Incidence and Predictors of Diabetes and Severe Hypertriglyceridemia, and their Complications.
Participants currently recruited/enrolled
3-125 Years
NIDDK
Disease
20-DK-0067
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared with PEG IFN-alfa-2a Monotherapy and Placebo Treatment i
No longer recruiting/follow-up only
18-125 Years
NIDDK
Disease
20-C-0167
Close Assessment and Testing for Chronic Graft-vs-Host Disease (CATCH Study)
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
20-C-0097
A Phase II, Open-Label Trial of Bintrafusp Alfa (M7824) in Subjects with Thymoma and Thymic Carcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
20-C-0070
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients with Inborn Errors of Immunity
Participants currently recruited/enrolled
4-69 Years
NCI
Disease
20-C-0062
A phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
20-C-0041
Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Enrolling by Invitation
1-125 Years
NCI
Disease
20-AA-0057
The Effect of Acute Alcohol Intoxication on Neural Processes During Decisions to Engage in HIV Risk Behaviors
Participants currently recruited/enrolled
21-65 Years
NIAAA
Disease
19-M-0095
PET Imaging of Neuroinflammation in Neurodegenerative Diseases via a Novel TSPO Radioligand
Participants currently recruited/enrolled
18-125 Years
NIMH
Disease
19-M-0079
Evaluation of Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis
Participants currently recruited/enrolled
18-99 Years
NIMH
Disease
19-I-0069
Phase I Open-Label Study of Safety and Immunogenicity of AD4-HIV Envelope Vaccine Vectors in Healthy Volunteers
Participants currently recruited/enrolled
18-65 Years
NIAID
Disease
19-HG-0101
A Phase 1/2 Study of Intravenous Gene Transfer with an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
No longer recruiting/follow-up only
0-12 Years
NHGRI
Disease
19-HG-0059
Longitudinal Studies of Patients with FPDMM
Participants currently recruited/enrolled
0-125 Years
NHGRI
Disease
19-EI-0056
A Survey Study of Retinitis Pigmentosa (RP) Clinical Measures and Repeatability Testing of Potential Outcome Measures.
Participants currently recruited/enrolled
12-125 Years
NEI
Disease
19-DK-0067
Effect of Low Fat versus Low Carbohydrate Diets on Energy Metabolism
Completed Study; data analyses ongoing
18-50 Years
NIDDK
Disease
19-CH-0020
A Phase 1-2 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children with Classic 21-Hydroxylase Deficiency
Recruitment has not started
2-9 Years
NICHD
Disease
19-C-0085
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T cell Lymphoma
Clinical hold/Recruitment or enrollment suspended
12-125 Years
NCI
Disease
18-N-0083
ASPIRO: A Phase 1/2/3, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Efficacy of AT132, an AAV8-Delivered Gene Therapy in X-Linked Myotubular Myopathy (XLMTM) Patients
No longer recruiting/follow-up only
3-5 Years
NINDS
X-Linked
18-I-0139
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
Completed Study; data analyses ongoing
18-64 Years
NIAID
Disease
18-I-0128
Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies
Participants currently recruited/enrolled
0-99 Years
NIAID
Disease
18-I-0092
A Phase 2, Open-Label Study to Assess the Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in Patients with Idiopathic CD4 T cell Lymphocytopenia
Participants currently recruited/enrolled
18-70 Years
NIAID
Disease
18-I-0041
Investigating the Mechanistic Biology of Primary Immunodeficiency Disorders
Participants currently recruited/enrolled
0-75 Years
NIAID
Disease
18-I-0022
Use of Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients with Leukocyte Adhesion Deficiency Type 1 (LAD1) who have Inflammatory Pathology
Participants currently recruited/enrolled
12-65 Years
NIAID
Recessive
18-HG-0129
Reverse Phenotyping Core (RPC)
Enrolling by Invitation
4-125 Years
NHGRI
Disease
18-H-0118
Technical and Translational Development of Cardiovascular MRI (CMR)
Participants currently recruited/enrolled
7-125 Years
NHLBI
Disease
18-H-0108
Vascular Disease Discovery Protocol
Participants currently recruited/enrolled
2-100 Years
NHLBI
Disease
18-H-0004
Low Dose Danazol for the Treatment of Telomere Related Diseases
Participants currently recruited/enrolled
3-125 Years
NHLBI
Disease
18-DK-0091
Long-Term Follow-Up Of Subjects With CHC Who Achieved A Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Participants currently recruited/enrolled
18-125 Years
NIDDK
Disease
18-D-0114
An Open Label Pilot Study of Denosumab Treatment for Fibrous Dysplasia
No longer recruiting/follow-up only
18-125 Years
NIDCR
Disease
18-CH-0031
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Participants currently recruited/enrolled
7-70 Years
NICHD
Disease
18-C-0138
An Open-Label Phase 2 Study to Evaluate PT2977 for the Treatment of Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma.
No longer recruiting/follow-up only
18-125 Years
NCI
Disease
18-C-0135
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Participants currently recruited/enrolled
4-125 Years
NCI
Disease
18-C-0076
Bicalutamide With or Without Metformin for Biochemical Recurrence in Prostate Cancer Patients (BIMET-1)
Completed Study; data analyses ongoing
18-85 Years
NCI
Disease
17-N-0131
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Participants currently recruited/enrolled
18-125 Years
NINDS
Disease
17-M-0179
Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)
Participants currently recruited/enrolled
18-99 Years
NIMH
Disease
17-I-0016
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)
Participants currently recruited/enrolled
0-99 Years
NIAID
Disease
17-H-0146
Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Completed Study; data analyses ongoing
18-100 Years
NHLBI
Disease
17-H-0091
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS using CordIn, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, to Expedite Engraftment and Improve Transplant Outcome
Participants currently recruited/enrolled
4-75 Years
NHLBI
Disease
17-C-0174
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
17-C-0105
Prospective Study of Clonal Evolution in Follicular Lymphoma
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
17-C-0086
An Open-label Phase 2 Study to Evaluate PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma
No longer recruiting/follow-up only
18-125 Years
NCI
Disease
16-I-0165
An open-label, non-randomized extension study to evaluate the long term safety, tolerability, efficacy and pharmacokinetics of CDZ173 (leniolisib) in patients with APDS/PASLI (Activated phosphoinositide 3-kinase delta syndrome/p110 delta-activating mutat
No longer recruiting/follow-up only
12-75 Years
NIAID
Disease
16-I-0065
Screening for Alpha Globin Deletions
Participants currently recruited/enrolled
18-39 Years
NIAID
Disease
16-HG-0156
The Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
Participants currently recruited/enrolled
0-125 Years
NHGRI
Disease
16-HG-0017
Genomic Services Research Program
Participants currently recruited/enrolled
0-125 Years
NHGRI
Disease
16-H-0074
Williams Syndrome (WS) and Supravalvular Aortic Stenosis (SVAS) DNA and Tissue Bank
Participants currently recruited/enrolled
0-85 Years
NHLBI
Disease
16-H-0063
Williams Syndrome Skin and Vascular Elasticity Study (WS-SAVE Study)
Completed Study; data analyses ongoing
1-70 Years
NHLBI
Disease
16-EI-0169
A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis
Completed Study; data analyses ongoing
18-125 Years
NEI
Disease
16-EI-0134
Studies of the Natural History, Pathogenesis and Outcome of Ocular Disorders
Participants currently recruited/enrolled
0-125 Years
NEI
Disease
16-EI-0104
Clinical and Molecular Studies in Families with Inherited Eye Disease
Participants currently recruited/enrolled
4-125 Years
NEI
Disease
16-EI-0024
Rod and Cone Mediated Function in Retinal Disease
Participants currently recruited/enrolled
5-125 Years
NEI
Disease
16-E-0096
Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
Participants currently recruited/enrolled
18-65 Years
NIEHS
Disease
16-DK-0125
Evaluation of Adults with Endocrine-Related Conditions
Participants currently recruited/enrolled
18-100 Years
NIDDK
Disease
16-DK-0068
The Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and its Role in Metabolism
Participants currently recruited/enrolled
18-125 Years
NIDDK
Disease
16-CH-0113
Evaluation of Children with Endocrine and Metabolic-Related Conditions
Participants currently recruited/enrolled
0-100 Years
NICHD
Disease
16-CC-0162
Longitudinal Changes in the Oral and Gut Microbiome of Individuals with Alcohol Dependence
Completed Study; data analyses ongoing
18-125 Years
CC
Disease
16-C-0154
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
16-C-0094
A Phase 1/2 Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (SCT)
No longer recruiting/follow-up only
18-125 Years
NCI
Disease
16-C-0003
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Participants currently recruited/enrolled
4-75 Years
NCI
Disease
15-N-0125
Natural History Study of Inflammatory and Infectious Diseases of the Nervous System
Participants currently recruited/enrolled
2-125 Years
NINDS
Disease
15-I-0135
An open-label, non-randomized, within-patient dose-finding study followed by a randomized, subject, investigator and sponsor-blinded placebo controlled study to assess the efficacy and safety of CDZ173 (leniolisib) in patients with APDS/PASLI (Activated
Completed Study; data analyses ongoing
12-75 Years
NIAID
Disease
15-I-0131
Xenodiagnosis after Antibiotic Treatment for Lyme Disease - Phase II Study
Completed Study; data analyses ongoing
18-125 Years
NIAID
Disease
15-I-0056
Collection of Plasma from Subjects that Recovered From or Were Vaccinated To Emerging Infectious Diseases
Enrolling by Invitation
18-70 Years
NIAID
Disease
15-I-0008
A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients with X-linked Chronic Granulomatous Disease (CGD)
Completed Study; data analyses ongoing
3-65 Years
NIAID
X-Linked
15-HG-0130
Clinical and Genetic Evaluation of Patients with Undiagnosed Disorders Through the Undiagnosed Diseases Network
Participants currently recruited/enrolled
0-100 Years
NHGRI
Disease
15-H-0190
Human Biospecimen Procurement and Analysis to Support Translational Research to Identify Genetic Etiology and Disease Mechanism(s) in Rare Genetic Vascular/Cardiovascular Diseases
Participants currently recruited/enrolled
0-125 Years
NHLBI
Disease
15-H-0155
Hereditary Parkinson Disease Natural History Protocol
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Recessive
15-EI-0128
The Genetics of Inherited Eye Disease
Participants currently recruited/enrolled
0-125 Years
NEI
Disease
15-EI-0038
A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
No longer recruiting/follow-up only
18-125 Years
NEI
X-Linked
15-EI-0020
Adaptive Optics Retinal Imaging
Participants currently recruited/enrolled
12-125 Years
NEI
Disease
15-DK-0108
Natural History of Noncirrhotic Portal Hypertension
Participants currently recruited/enrolled
12-125 Years
NIDDK
Disease
15-D-0051
Characterization of Diseases with Salivary Gland Involvement
Participants currently recruited/enrolled
4-125 Years
NIDCR
Disease
15-C-0157
Phase I/II Trial of Vandetanib in Combination with Metformin in Subjects with HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
Completed Study; data analyses ongoing
18-125 Years
NCI
Disease
15-C-0099
A Phase 1, Open-Label, Dose-Escalation Study of SNX-5422 and Everolimus in Subjects with Neuroendocrine Tumors
Completed Study; data analyses ongoing
18-100 Years
NCI
Disease
15-C-0067
A Phase I/II Open Label, Dose Escalation Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
15-AR-0144
Studies of Dermatologic Diseases-Biospecimen Acquisition Protocol
Participants currently recruited/enrolled
2-125 Years
NIAMS
Disease
15-AG-0123
Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function
Completed Study; data analyses ongoing
55-70 Years
NIA
Disease
15-AG-0063
The Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
Participants currently recruited/enrolled
20-125 Years
NIA
Disease
14-I-0194
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Participants currently recruited/enrolled
18-65 Years
NIAID
Disease
14-I-0146
The Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Participants currently recruited/enrolled
2-100 Years
NIAID
Disease
14-I-0091
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
Completed Study; data analyses ongoing
3-125 Years
NIAID
Disease
14-I-0039
Elite Controller and ART-Treated HIV+ Statin Versus ASA Treatment Intervention Study
Completed Study; data analyses ongoing
18-125 Years
NIAID
Disease
14-HG-0071
Clinical and Basic Investigations into Known and Suspected Congenital Disorders of Glycosylation
Participants currently recruited/enrolled
1-80 Years
NHGRI
Disease
14-AR-0200
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Participants currently recruited/enrolled
3-125 Years
NIAMS
Disease
14-AA-0144
Reliability Of The Human Brain Connectome
Participants currently recruited/enrolled
18-125 Years
NIAAA
Disease
13-N-0188
Natural History and Biomarkers of C9ORF72 Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Completed Study; data analyses ongoing
18-125 Years
NINDS
Disease
13-N-0165
Electrical Impedance Myography: Natural History Studies in Neuromuscular Disorders and Healthy Volunteers
Participants currently recruited/enrolled
2-125 Years
NINDS
Disease
13-N-0140
Cerebrospinal Fluid Collection and Repository Storage
Participants currently recruited/enrolled
2-125 Years
NINDS
Disease
13-I-0177
Natural History Study of the Complications Associated with Allogeneic Hematopoietic Stem Cell Transplantations
Completed Study; data analyses ongoing
2-125 Years
NIAID
Disease
13-I-0082
Rituximab (Anti-CD20) for the Treatment of Subjects With Anticytokine Autoantibody-Associated Diseases
Completed Study; data analyses ongoing
18-125 Years
NIAID
Disease
13-HG-0199
NIH Participation to USIDNET Registry
Participants currently recruited/enrolled
0-125 Years
NHGRI
Disease
13-HG-0053
The NIH Mini Study: Metabolism, INfection and Immunity in Inborn Errors of Mitochondrial Metabolism
Participants currently recruited/enrolled
2-125 Years
NHGRI
Disease
13-H-0194
Inflammatory Characterization of Known or Possible Cardiovascular Diseases
No longer recruiting/follow-up only
18-125 Years
NHLBI
Disease
13-H-0116
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
Participants currently recruited/enrolled
4-125 Years
NHLBI
Disease
13-H-0065
Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic Disease (PACI) Initiative
No longer recruiting/follow-up only
18-125 Years
NHLBI
Disease
13-EI-0072
Microbiome and Ocular Inflammatory Disease
Completed Study; data analyses ongoing
18-125 Years
NEI
Disease
13-D-0033
Diagnosis and Treatment of Patients in Need of Third Molar Removal and Oral Specimen Acquisition
Participants currently recruited/enrolled
16-50 Years
NIDCR
Disease
13-D-0014
Bacterial Arrangement in Supragingival Biofilms
Completed Study; data analyses ongoing
18-999 Years
NIDCR
Disease
13-CC-0012
A Natural History Study of Novel Biomarkers in Pulmonary Arterial Hypertension
Participants currently recruited/enrolled
18-125 Years
CC
Disease
13-C-0153
A Phase II Trial of Enzalutamide in Combination with PSA-TRICOM in Patients with Non-Metastatic Castration Sensitive Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
Disease
13-C-0132
Allogeneic Hematopoietic Stem Cell Transplant for Patients with Mutations in GATA2 or the MonoMAC Syndrome
Participants currently recruited/enrolled
8-70 Years
NCI
Disease
13-C-0131
Inpatient Hospice with Procurement of Tissue on Expiration in Thoracic Malignancies, Bladder Cancer, Ovarian Cancer, Epithelial Cancer and Patients Treated with an Adoptive Cellular Therapy
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
13-AR-0056
Stopping Tumor Necrosis Factor-Alpha Inhibitors in Rheumatoid Arthritis
Completed Study; data analyses ongoing
18-125 Years
NIAMS
Disease
12-HG-0181
The Clinical Study of Patients with Sex Chromosome Variants
Completed Study; data analyses ongoing
18-125 Years
NHGRI
Disease
12-HG-0022
Inherited Diseases, Caregiving, and Social Networks
Completed Study; data analyses ongoing
18-125 Years
NHGRI
Disease
12-H-0064
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications
Participants currently recruited/enrolled
4-75 Years
NHLBI
Disease
12-EI-0203
Natural History of ABCA4-Related Retinopathies
No longer recruiting/follow-up only
12-125 Years
NEI
Disease
12-EI-0042
NEI Intramural Biorepository for Retinal Diseases
Participants currently recruited/enrolled
2-125 Years
NEI
Disease
12-E-0190
The Role of Functionally Relevant Cyclooxygenase-2 (COX-2) Gene Single Nucleotide Polymorphisms - 765G>C and 8473T>C in Lymphocyte Differentiation
Completed Study; data analyses ongoing
18-150 Years
NIEHS
Disease
12-E-0061
The Role of the Functionally Relevant Single Nucleotide Polymorphisms CYP2J2 -50G>T (CYP2J2 7) and EPHX2 9846A>G (EPHX2 K55R) in Human Endothelial Function
Completed Study; data analyses ongoing
18-65 Years
NIEHS
Disease
12-AR-0159
Effects of Treatments on the Microbiome in Healthy Volunteers and Patients with Atopic Dermatitis
Participants currently recruited/enrolled
2-50 Years
NIAMS
Disease
11-I-0183
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
Participants currently recruited/enrolled
18-65 Years
NIAID
Disease
11-I-0164
VRC 500: Screening Volunteers for Clinical Trials of Investigational Products and Licensed Products Evaluated for Research Purposes
Participants currently recruited/enrolled
18-125 Years
NIAID
Disease
11-I-0109
Viral Infections in Healthy and Immunocompromised Hosts
Participants currently recruited/enrolled
0-125 Years
NIAID
Disease
11-I-0007
Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age with X-Linked Severe Combined Immunodeficiency
Clinical hold/Recruitment or enrollment suspended
2-40 Years
NIAID
X-Linked
11-HG-0218
A Natural History Study of Patients with GNE Myopathy and GNE-Related Diseases
Participants currently recruited/enrolled
4-80 Years
NHGRI
Disease
11-HG-0110
Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations
Enrolling by Invitation
18-125 Years
NHGRI
Disease
11-H-0209
Male Hormones for Telomere Related Diseases
Completed Study; data analyses ongoing
2-125 Years
NHLBI
Disease
11-H-0134
A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Moderate Aplastic Anemia Patients
No longer recruiting/follow-up only
2-125 Years
NHLBI
Disease
11-H-0046
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Completed Study; data analyses ongoing
18-125 Years
NHLBI
Disease
11-EI-0245
Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls
Participants currently recruited/enrolled
1-125 Years
NEI
Disease
11-E-0072
Environmental Risk Factors for the Anti-Synthetase Syndrome
Participants currently recruited/enrolled
2-100 Years
NIEHS
Disease
11-CC-0120
Stereophotogrammetry of the Torso in Healthy Individuals and Patients with Scoliosis, Chest Wall Deformations, or Obesity
Completed Study; data analyses ongoing
2-125 Years
CC
Disease
10-I-0197
Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases
Participants currently recruited/enrolled
2-99 Years
NIAID
Disease
10-I-0148
Natural History of Severe Allergic Inflammation and Reactions
Participants currently recruited/enrolled
2-80 Years
NIAID
Disease
10-I-0139
Searching for Persistence of Infection in Lyme Disease
Completed Study; data analyses ongoing
18-125 Years
NIAID
Disease
10-I-0109
VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Participants currently recruited/enrolled
18-125 Years
NIAID
Disease
10-HG-0065
Whole Genome Medical Sequencing for Gene Discovery
Participants currently recruited/enrolled
0-125 Years
NHGRI
Disease
10-H-0154
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused with a Reduced Dose of Non-Mobilized Donor T-Cells
Participants currently recruited/enrolled
4-80 Years
NHLBI
Disease
10-H-0126
Cardiovascular Disease Discovery Protocol
Participants currently recruited/enrolled
1-100 Years
NHLBI
Disease
10-EI-0140
Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity
Participants currently recruited/enrolled
18-125 Years
NEI
Disease
10-E-0134
Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
Completed Study; data analyses ongoing
18-100 Years
NIEHS
Disease
10-E-0129
Study of the Effect of Innate Immunity on the Inflammatory Response to Endotoxin
Participants currently recruited/enrolled
18-125 Years
NIEHS
Disease
10-CC-0053
Collection of Bone Marrow from Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
Completed Study; data analyses ongoing
18-125 Years
CC
Disease
10-C-0201
Apheresis and CD34+ Selection of Mobilized Peripheral Blood CD34+ Cells from Patients with DOCK8 Deficiency, LAD-1, and GATA2 Deficiency
Participants currently recruited/enrolled
18-40 Years
NCI
Disease
10-C-0066
A Study of Hairy Cell and other Leukemias with a Focus on Recombinant Immunotoxins for Cancer Treatment
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
10-C-0056
A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas
Completed Study; data analyses ongoing
18-125 Years
NCI
Disease
09-NR-0088
Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy
Completed Study; data analyses ongoing
18-125 Years
NINR
Disease
09-N-0010
Biomarkers of Risk of Parkinson Disease
Completed Study; data analyses ongoing
18-70 Years
NINDS
Disease
09-I-0133
Establishing Fibroblast-derived Cell Lines from Skin/Tissue Biopsies of Patients with Immunodeficiency or Immunodysregulation Disorders
Enrolling by Invitation
2-85 Years
NIAID
Disease
09-I-0102
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Participants currently recruited/enrolled
18-125 Years
NIAID
Disease
09-I-0086
Screening Protocol for Genetic Diseases of Allergic Inflammation
Participants currently recruited/enrolled
0-99 Years
NIAID
Disease
09-I-0032
Comprehensive Multimodal Analysis of Patients with Neuroimmunological Diseases of the CNS
Participants currently recruited/enrolled
0-99 Years
NIAID
Disease
09-H-0172
Natural History of Bronchiectasis
Participants currently recruited/enrolled
5-125 Years
NHLBI
Disease
09-DK-0223
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Participants currently recruited/enrolled
18-125 Years
NIDDK
Disease
09-C-0024
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents and Young Adults
Completed Study; data analyses ongoing
12-26 Years
NCI
Disease
09-C-0005
Randomized Trial of Cladribine (CdA) with Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual Disease
Participants currently recruited/enrolled
18-125 Years
NCI
Disease
08-EI-0102
Screening Protocol for the Evaluation and Diagnosis of Potential Research Participants
Participants currently recruited/enrolled
2-125 Years
NEI
Disease
08-EI-0031
Visual Motor Coordination
Participants currently recruited/enrolled
18-125 Years
NEI
Disease
07-H-0142
Research Respiratory Tract Procedures
Participants currently recruited/enrolled
10-125 Years
NHLBI
Disease
07-H-0113
Procurement and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples from Healthy Volunteers to Support Clinical and Translational Research Projects in the NHLBI
Participants currently recruited/enrolled
8-125 Years
NHLBI
Disease
07-E-0023
Innate Immunity Signal Transduction in Human Leukocytes
Participants currently recruited/enrolled
18-65 Years
NIEHS
Disease
07-CH-0008
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Completed Study; data analyses ongoing
18-85 Years
NICHD
Disease
06-M-0214
PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome
Completed Study; data analyses ongoing
18-24 Years
NIMH
Disease
06-I-0015
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Participants currently recruited/enrolled
0-125 Years
NIAID
Disease
06-H-0217
Genetic Disorders of Mucociliary Clearance
Completed Study; data analyses ongoing
2-65 Years
NHLBI
Disease
06-EI-0236
National Ophthalmic Genotyping and Phenotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
No longer recruiting/follow-up only
2-125 Years
NEI
Disease
06-CH-0011
Natural History Study of Patients with Excess Androgen
Participants currently recruited/enrolled
0-99 Years
NICHD
Disease
06-C-0014
Prospective Evaluation of Genetic and Epigenetic Alterations in Patients with Thoracic Malignancies
Participants currently recruited/enrolled
2-125 Years
NCI
Disease
05-I-0213
Screening and Baseline Assessment of Patients with Abnormalities of Immune Function
Participants currently recruited/enrolled
0-125 Years
NIAID
X-Linked
05-CC-0216
Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation
Completed Study; data analyses ongoing
18-125 Years
CC
Disease
04-H-0012
Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples from Patients with Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members
Participants currently recruited/enrolled
2-125 Years
NHLBI
Disease
04-E-0053
Personalized Environment and Genes Study
Participants currently recruited/enrolled
18-130 Years
NIEHS
Disease
04-CH-0077
Investigations of Bone-Related Connective Tissue Disorders
Completed Study; data analyses ongoing
0-70 Years
NICHD
Disease
03-I-0263
VRC 200: A Multicenter Specimen Collection Protocol to Obtain Human Biological Samples for Research Studies
Participants currently recruited/enrolled
18-125 Years
NIAID
Disease
03-H-0280
Disease Pathogenesis and Natural History of Lipid Disorders
Participants currently recruited/enrolled
2-100 Years
NHLBI
Disease
03-EI-0033
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies
Participants currently recruited/enrolled
0-125 Years
NEI
X-Linked
03-E-0099
Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders
Completed Study; data analyses ongoing
2-125 Years
NIEHS
Disease
03-AR-0173
Studies of Natural History, Pathogenesis, and Outcomes in Autoimmune and Inflammatory Diseases Including Juvenile Dermatomyositis
Participants currently recruited/enrolled
2-125 Years
NIAMS
Disease
02-N-0014
Research Study of Specimens Obtained During Epilepsy Surgery
Completed Study; data analyses ongoing
4-125 Years
NINDS
Disease
02-I-0147
Genetic Studies of Chronic Active Epstein-Barr Virus Infection
Participants currently recruited/enrolled
1-125 Years
NIAID
Disease
02-HG-0107
Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders
Participants currently recruited/enrolled
0-125 Years
NHGRI
Disease
02-CH-0311
Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders
Participants currently recruited/enrolled
0-125 Years
NICHD
X-Linked
02-C-0210
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy
Participants currently recruited/enrolled
0-125 Years
NCI
Disease
01-N-0206
Phenotype/Genotype Correlations in Movement Disorders
Participants currently recruited/enrolled
2-125 Years
NINDS
Disease
01-N-0007
Evaluation, Pathogenesis, and Treatment of Patients with or at Risk for Cerebrovascular Disease (A Natural History/Disease Pathogenesis Protocol)
Participants currently recruited/enrolled
18-125 Years
NINDS
Disease
01-I-0238
Host Response to Infection and Treatment in Leishmania Infection of Humans
Participants currently recruited/enrolled
3-100 Years
NIAID
Disease
01-I-0202
Natural History, Genetics, Phenotype, and Treatment of Mycobacterial Infections
Participants currently recruited/enrolled
0-100 Years
NIAID
Disease
01-H-0122
Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy
Participants currently recruited/enrolled
18-45 Years
NHLBI
Disease
01-DK-N117
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NIDDK
Disease
01-D-0184
A Natural History Study of Bone and Mineral Disorders
Participants currently recruited/enrolled
0-125 Years
NIDCR
Disease
01-C-0009
Breast Imaging Screening Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study
Completed Study; data analyses ongoing
18-100 Years
NCI
Disease
01-AR-0227
Studies of the Natural History of Rheumatic Disease in Minority Communities
Participants currently recruited/enrolled
18-100 Years
NIAMS
Disease
00-N-0043
Clinical and Molecular Manifestations of Inherited Neurological Disorders
Participants currently recruited/enrolled
2-125 Years
NINDS
Disease
00-I-0159
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Participants currently recruited/enrolled
0-125 Years
NIAID
Disease
00-HG-0153
Investigations into Chediak-Higashi Syndrome and Related Disorders
Participants currently recruited/enrolled
0-70 Years
NHGRI
Recessive
00-CH-0093
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma
Participants currently recruited/enrolled
3-125 Years
NICHD
Disease
99-H-0050
Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases
Completed Study; data analyses ongoing
2-80 Years
NHLBI
Disease
99-DK-0002
Diabetes and Heart Disease Risk in Blacks
Participants currently recruited/enrolled
18-70 Years
NIDDK
Disease
99-C-0099
Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Participants currently recruited/enrolled
0-125 Years
NCI
Disease
98-CH-0081
Clinical and Basic Investigations into Smith-Lemli-Opitz Syndrome
Completed Study; data analyses ongoing
0-125 Years
NICHD
Recessive
98-CC-0019
Volunteer Scanning on MR
Participants currently recruited/enrolled
18-125 Years
CC
Disease
97-HG-0192
Genetic Studies in the Amish and Mennonites
Completed Study; data analyses ongoing
18-125 Years
NHGRI
Disease
97-C-0147
Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Diseases
Participants currently recruited/enrolled
2-125 Years
NCI
Disease
96-H-0100
Role of Genetic Factors in the Pathogenesis of Lung Disease
Participants currently recruited/enrolled
2-90 Years
NHLBI
Disease
96-AR-0102
Evaluation and Treatment of Subjects with Dermatologic Diseases
Participants currently recruited/enrolled
0-125 Years
NIAMS
Disease
96-AR-0097
The Acquisition of Blood and Skin Samples from Patient Volunteers to Support Research Activities on Dermatologic and Other Diseases
No longer recruiting/follow-up only
18-125 Years
NIAMS
Disease
95-I-0066
Genetic Analysis of Immune Disorders
Participants currently recruited/enrolled
0-125 Years
NIAID
Disease
95-CH-0059
Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions
Completed Study; data analyses ongoing
3-70 Years
NICHD
Disease
94-I-0079
Eosinophil Activation and Function in Parasitic Infections and Other Conditions with Increased Tissue or Peripheral Blood Eosinophilia in Humans
Participants currently recruited/enrolled
1-100 Years
NIAID
Disease
94-I-0073
Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Participants currently recruited/enrolled
18-70 Years
NIAID
X-Linked
94-HG-0105
An Exploratory Study of the Genetics, Pathophysiology, and Natural History of Autoinflammatory Diseases
Participants currently recruited/enrolled
0-125 Years
NHGRI
Disease
94-DK-0133
Genetic Markers for Focal Segmental Glomerulosclerosis
Completed Study; data analyses ongoing
1-125 Years
NIDDK
Disease
94-DK-0127
Pathogenesis of Glomerulosclerosis
Completed Study; data analyses ongoing
2-125 Years
NIDDK
Disease
93-I-0119
Detection and Characterization of Host Defense Defects
Participants currently recruited/enrolled
0-125 Years
NIAID
Disease
93-I-0086
Evaluation and Long-Term Follow-Up of Patients with Acute or Chronic Inflammatory Disorders
Enrolling by Invitation
2-125 Years
NIAID
Disease
92-DK-0156
Studies of Immunologically-Mediated Kidney Diseases
Participants currently recruited/enrolled
10-125 Years
NIDDK
Disease
91-I-0140
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in HIV-Infected and HIV-Uninfected Volunteers
Participants currently recruited/enrolled
18-125 Years
NIAID
Disease
91-DK-0214
Evaluation of Patients with Liver Disease
Participants currently recruited/enrolled
2-125 Years
NIDDK
Disease
91-AR-0196
Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases
Participants currently recruited/enrolled
16-125 Years
NIAMS
Disease
90-CC-0168
A Rigid Body Database on Human Movement
Participants currently recruited/enrolled
0-125 Years
CC
Disease
89-N-0045
Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI)
Participants currently recruited/enrolled
18-125 Years
NINDS
Disease
88-I-0083
Host Response to Infection and Treatment in the Filarial Diseases of Humans
Participants currently recruited/enrolled
3-100 Years
NIAID
Disease
82-I-0183
A Natural History Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut
Participants currently recruited/enrolled
0-75 Years
NIAID
Disease
79-H-0100
Teaching Protocol for the Evaluation of Plasma Lipoproteins
No longer recruiting/follow-up only
2-99 Years
NHLBI
Disease
78-I-0023
Diagnosis and Management of Inflammatory and Infectious Diseases
Participants currently recruited/enrolled
3-125 Years
NIAID
Disease
76-HG-0238
Diagnosis and Treatment of Patients with Inborn Errors of Metabolism or Other Genetic Disorders
Participants currently recruited/enrolled
0-125 Years
NHGRI
Disease